Literature DB >> 9603916

The INS 5' variable number of tandem repeats is associated with IGF2 expression in humans.

J Paquette1, N Giannoukakis, C Polychronakos, P Vafiadis, C Deal.   

Abstract

The minisatellite DNA polymorphism consisting of a variable number of tandem repeats (VNTR) at the human INS (insulin gene) 5'-flanking region has demonstrated allelic effects on insulin gene transcription in vitro and has been associated with the level of insulin gene expression in vivo. We now show that this VNTR also has effects on the nearby insulin-like growth factor II gene (IGF2) in human placenta in vivo and in the HepG2 hepatoma cell line in vitro. We show that higher steady-state IGF2 mRNA levels are associated with shorter alleles (class I) than the longer class III alleles in term placentae. In vitro, reporter gene activity was greater from reporter gene constructs with IGF2 promoter 3 in the presence of class I alleles than from those with class III. Taken together with the documented transcriptional effects on the insulin gene, we propose that the VNTR may act as a long range control element affecting the expression of both INS and IGF2. The localization of a type 1 diabetes susceptibility locus (IDDM2) to the VNTR itself suggests that either or both of these genes may be involved in the biologic effects of IDDM2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603916     DOI: 10.1074/jbc.273.23.14158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

3.  Comparative analyses of human single- and multilocus tandem repeats.

Authors:  Darren Ames; Nick Murphy; Tim Helentjaris; Nina Sun; Vicki Chandler
Journal:  Genetics       Date:  2008-06-18       Impact factor: 4.562

Review 4.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

5.  Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.

Authors:  Maheswari Thangavelu; Usha Rani Godla; F D Paul Solomon; Ravi Maddaly
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

Review 6.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

7.  Genetics of polycystic ovary syndrome.

Authors:  N Prapas; A Karkanaki; I Prapas; I Kalogiannidis; I Katsikis; D Panidis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

8.  Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and influence gene expression.

Authors:  Se-Lyun Yoon; Se-Il Jung; Eun-Ju Do; Se-Ra Lee; Sang-Yeop Lee; In-Sun Chu; Wun-Jae Kim; Jaeil Jung; Choung Soo Kim; Sang-Hyeon Cheon; Sun-Hee Leem
Journal:  BMC Cancer       Date:  2010-07-26       Impact factor: 4.430

9.  Large-scale studies of the HphI insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin release.

Authors:  S K Hansen; A P Gjesing; S K Rasmussen; C Glümer; S A Urhammer; G Andersen; C S Rose; T Drivsholm; S K Torekov; D P Jensen; C T Ekstrøm; K Borch-Johnsen; T Jørgensen; M I McCarthy; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2004-05-29       Impact factor: 10.122

10.  Common polymorphic variation in the genetically diverse African insulin gene and its association with size at birth.

Authors:  Clive J Petry; Pura Rayco-Solon; Anthony J C Fulford; John D H Stead; Dianne L Wingate; Ken K Ong; Giorgio Sirugo; Andrew M Prentice; David B Dunger
Journal:  Hum Genet       Date:  2009-05-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.